Basic pharmacodynamic models for agents that alter the lifespan distribution of natural cells.
about
Lifespan based pharmacokinetic-pharmacodynamic model of tumor growth inhibition by anticancer therapeuticsMathematical model of platelet turnover in thrombocytopenic and nonthrombocytopenic preterm neonatesRibavirin-induced anemia in hepatitis C virus patients undergoing combination therapy.Development of an erythropoietin prescription simulator to improve abilities for the prescription of erythropoietin stimulating agents: is it feasible?Simultaneous pharmacokinetics/pharmacodynamics modeling of recombinant human erythropoietin upon multiple intravenous dosing in ratsInterpretation of transit compartments pharmacodynamic models as lifespan based indirect response modelsComparative performance of cell life span and cell transit models for describing erythropoietic drug effectsPopulation pharmacokinetic and pharmacodynamic model-based comparability assessment of a recombinant human Epoetin Alfa and the Biosimilar HX575.Models for the red blood cell lifespan.Pharmacodynamic modeling of the effect of changes in the environment on cellular lifespan and cellular response.Lifespan based indirect response models.Modeling of delays in PKPD: classical approaches and a tutorial for delay differential equations.Tools for predicting the PK/PD of therapeutic proteins.Pharmacodynamic models of age-structured cell populations.A semi-mechanistic red blood cell survival model provides some insight into red blood cell destruction mechanisms.
P2860
Q28543966-18E4EB0B-951C-4382-BA73-A56EE23996F0Q33418500-2CD73866-0D29-4F72-B0EF-64A7BB861D51Q33815550-F5EA2460-7519-4F20-8C04-06A29ADEBEE6Q33824163-21288C36-BF06-41D1-B32E-85C7C879B809Q34128875-CB60F973-145E-4F35-B27B-7748FDCFA074Q35226129-737BD103-CD36-4C94-8514-CF272094E0DFQ35595803-5B3731DD-834E-460D-8023-6C13791D0963Q36354544-9003A7DA-64B0-46FA-A955-32C7EADAAAC3Q36952011-D7EAE6DC-FE36-4B66-AA5F-D1BDB21287FEQ37363462-26A4FA10-5804-4DE9-83B2-3F4C1CA96ADBQ37972792-CBA15114-D2A0-4F6A-A822-AD9B3DBF6D0BQ38241696-6D23DE90-0FB2-44D1-98DC-2229A14C9C5AQ38455786-D1441C2D-4168-4BE5-A2B1-2EE0CF093893Q38588105-4463052E-CE53-49CE-BA6B-7E0EADA8F318Q50489599-E7A2C720-5CE8-4C99-BCFB-245F66FBEBBA
P2860
Basic pharmacodynamic models for agents that alter the lifespan distribution of natural cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Basic pharmacodynamic models f ...... distribution of natural cells.
@en
Basic pharmacodynamic models f ...... distribution of natural cells.
@nl
type
label
Basic pharmacodynamic models f ...... distribution of natural cells.
@en
Basic pharmacodynamic models f ...... distribution of natural cells.
@nl
prefLabel
Basic pharmacodynamic models f ...... distribution of natural cells.
@en
Basic pharmacodynamic models f ...... distribution of natural cells.
@nl
P2093
P2860
P1476
Basic pharmacodynamic models f ...... distribution of natural cells.
@en
P2093
An Vermeulen
Juan Jose Perez-Ruixo
Wojciech Krzyzanski
P2860
P2888
P304
P356
10.1007/S10928-008-9092-6
P577
2008-06-13T00:00:00Z